NCT04512547View on ClinicalTrials.gov

Oxidative Stress in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
AsthmaObesity
Interventions
DRUG

Hyperpolarized 129XeMRI

Images obtained using 129XeMRI will be obtained on both obese asthmatic and non-asthmatics

Trial Locations (1)

27705

Duke Asthma Allergy and Airway Center, Durham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Bastiaan Driehuys

OTHER

NCT04512547 - Oxidative Stress in Asthma | Biotech Hunter | Biotech Hunter